It was kind of a consolidation day on Wall Street on Monday. The market was down, but it looked like the indices didn’t want to take them too far down. Certainly, a lot of our stocks are still acting well.
Inovio Pharmaceuticals Inc (NASDAQ:INO) is acting great, but a little long in the tooth. It was up 41 cents to 9.66, or 4.4%, on nearly 3 million shares on Monday. It got up to 9.90, which is the first target that was put on this stock. The second target is around 11.00.
Primo Water Corporation (NASDAQ:PRMW) is acting well. After breaking out it’s run up four days in a row. It’s touching secondary resistance and my first target at 11.00. The second target is 13 1/2-14.
Shutterstock (NYSE:SSTK), a swing trade of ours, finally got a breakout on Monday, up 77 cents to 38.24, or 2%, on 356,300 shares traded. It popped as high as 40, but finished at 38.24. It made it over the hump and may very well consolidate for a day or two and continue. Targets are 44 and 50-52 going forward.
Stocks on the long side included ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), Boston Scientific Corporation (NYSE:BSX), Celator Pharm (NASDAQ:CPXX), 3D Systems Corporation (NYSE:DDD), Editas Medicine Inc (NASDAQ:EDIT), Fireeye Inc (NASDAQ:FEYE), Genocea Bioscnc (NASDAQ:GNCA), Groupon Inc (NASDAQ:GRPN), Hawaiian Holdings Inc (NASDAQ:HA), Inovio Pharmaceuticals Inc (NASDAQ:INO), Direxion Daily S&P Biotech Bull 3X Shares (NYSE:LABU), MediciNova Inc (NASDAQ:MNOV), Ocular Therapeutix Inc (NASDAQ:OCUL), Primo Water Corporation (NASDAQ:PRMW), Sientra Inc (NASDAQ:SIEN), Sky Solar Holdings Adr Rep 8 (NASDAQ:SKYS), Sorrento Therape (NASDAQ:SRNE), Shutterstock (NYSE:SSTK), Stratasys Ltd (NASDAQ:SSYS), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Transenterix Inc (NYSE:TRXC), and TherapeuticsMD Inc (NYSE:TXMD).